Trinity Biotech: Rises after COVID-19 test gets EU nod

Trinity Biotech

05/01/2021 14:29

** U.S.-listed shares of diagnostic products maker  TRIB.O 
rise 7.2% to $3.87 in premarket trade
    ** Co says it received European Union (EU) approval for use
of its COVID-19 antibody test  urn:newsml:reuters.com:*:nGNX8KqwLs
    ** CE mark certification, which implies the test complies
with EU's in vitro diagnostic directive, was awarded to TRIB's 
Captia SARS-CoV-2 IgG ELISA test
    ** In August, TRIB filed its submission for Emergency Use
Authorization (EUA) for the test with U.S. FDA

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))